Collaboration is the key to a more holistic view and good health economics and the pharmaceutical industry should be a key player in this. At the same time, it may be high time for the pharmaceutical industry to revise not only its own strategies, but also its self image: To dare to stand for and communicate what the industry actually does and can do in the future. These are some of the results of this year’s industry study conducted by Opticom International Research in collaboration with the Pharma Industry and LIF.
Opticom International Research has since 2010 every year conducted a study in the Swedish pharmaceutical industry in collaboration with Pharma Industry, where people working in the pharmaceutical industry will offer their opinions and predictions for the industry. Since 2012, LIF (the trade association for the research-based pharmaceutical industry in Sweden) has also participated in conducting the study. The aim of the study is to identify the industry’s perception of itself and the perception of its role within the Swedish health care system in order to identify both opportunities and threats for the future.
Click here to read the full article about this survey on the pharmaceutical industry (in Swedish).
The unique Almedalen week is quickly approaching and on Wednesday the 2nd of July, Opticom invites to an After work event starting at 5 pm.
This year, we are organising the event together with Magnusson, the Baltic Sea Region Law Firm. In addition to rosé wine and sushi, we offer a highly topical, interesting conversation with experienced diplomats Ekéus and Mats Hellström on developments around the Baltic Sea.
To access the invitation, click here.
NB! Please notice that places are limited. To register, please send an e-mail to email@example.com or Carl Michael Bergman at Opticom.
Opticom attended Läkemedelsdagen 2014 at Nalen where the road to a more equal health care for all was in focus.
Ordnat införande, horizon scanning and structured follow-up were topics that were presented and discussed. In the panel discussions where Anders Blanck, LIF, Hans Karlsson, SKL, Heidi Stensmyren, Läkarförbundet and Calle Waller, Prostatacancerförbundet participated, critiscism was expressed against the models’ focus to be more on order and structure and follow-up and very little on introduction.
There are different roads to take, either you can act in the existing systems, i.e. to do something that may not be good, but at least better than what is done today or you can do something new and make a difference. Representatives for the industry, patients and clinics consider “ordnat införande” to be a far too weak effort and point out there is a greater need for speed that cannot be accommodated in the current systems.
During the day more criticism was expressed towards the current health care system in Sweden:
“Today we have a very weak uptake of new drugs in Sweden and that is a major issue. Many believe we still have a growing budget for pharmaceuticas in Sweden, but this belief is wrong, this budget has not increased in many years.” (Robert Ström, LIF)
“There is a lot of money that is used wrongly in the health care system in Sweden. If we would use the money in the right way, we would not need any private health insurances. Just to move a recycle bin for batteries 2 meters can save hours for health care personnel and before we have looked at all these kinds of improvements, I think we should not start to discuss private health insurances.” (Barbro Westerholm (FP), member of parliament)